Your browser doesn't support javascript.
loading
A novel anticancer quinolone, (R)-WAC-224, has anti-leukemia activities against acute myeloid leukemia.
Mino, Tatsuji; Ureshino, Hiroshi; Ueshima, Taichi; Kashimoto, Naoki; Yamaguchi, Tomonori; Naka, Kazuhito; Inaba, Toshiya; Ichinohe, Tatsuo.
Afiliação
  • Mino T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Ureshino H; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. hureshin@hiroshima-u.ac.jp.
  • Ueshima T; Drug Discovery Laboratory, Wakunaga Pharmaceutical Co., Ltd, Hiroshima, Japan.
  • Kashimoto N; Drug Discovery Laboratory, Wakunaga Pharmaceutical Co., Ltd, Hiroshima, Japan.
  • Yamaguchi T; Drug Discovery Laboratory, Wakunaga Pharmaceutical Co., Ltd, Hiroshima, Japan.
  • Naka K; Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Inaba T; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Invest New Drugs ; 41(5): 751-760, 2023 10.
Article em En | MEDLINE | ID: mdl-37702844

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Quinolonas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Quinolonas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article